Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

BlackRock, Inc. reported a 5.50% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Jul 17, 2025

BlackRock, Inc. reported a 5.50% stake in Amylyx Pharmaceuticals, Inc., 4,917,501 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).

Stake
5.50%
Shares
4,917,501
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.50%4,917,501

Source

View original at SEC

Related